Works matching IS 13866346 AND DT 2024 AND VI 54 AND IP 5


Results: 12
    1
    2
    3
    4
    5
    6
    7
    8

    Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2024, v. 54, n. 5, p. 451, doi. 10.1111/hepr.13995
    By:
    • Yoshimaru, Yoko;
    • Nagaoka, Katsuya;
    • Tanaka, Kentaro;
    • Narahara, Satoshi;
    • Inada, Hiroki;
    • Kurano, Sotaro;
    • Tokunaga, Takayuki;
    • Iio, Etsuko;
    • Watanabe, Takehisa;
    • Setoyama, Hiroko;
    • Tateyama, Masakuni;
    • Yoshida, Koji;
    • Tsunoda, Takuya;
    • Nakamura, Yusuke;
    • Tanaka, Motohiko;
    • Sasaki, Yutaka;
    • Tanaka, Yasuhito
    Publication type:
    Article
    9
    10
    11

    Issue Information.

    Published in:
    Hepatology Research, 2024, v. 54, n. 5, p. 413, doi. 10.1111/hepr.13917
    Publication type:
    Article
    12

    Metabolic dysfunction‐associated steatotic liver disease criteria may underestimate the number of lean female nonalcoholic fatty liver disease patients with significant liver fibrosis.

    Published in:
    Hepatology Research, 2024, v. 54, n. 5, p. 429, doi. 10.1111/hepr.13994
    By:
    • Kobayashi, Natsuko;
    • Tada, Toshifumi;
    • Nishimura, Takashi;
    • Matono, Tomomitsu;
    • Yuri, Yukihisa;
    • Takashima, Tomoyuki;
    • Aizawa, Nobuhiro;
    • Ikeda, Naoto;
    • Fukunishi, Shinya;
    • Hashimoto, Mariko;
    • Ohyanagi, Mitsumasa;
    • Enomoto, Hirayuki;
    • Iijima, Hiroko
    Publication type:
    Article